Researchers are working on a new approach to target autoimmunity in the brain — a condition at the core of several diseases, including multiple sclerosis.

Researchers from Brigham and Women’s Hospital, King’s College London, and other institutions have developed a technique for measuring brain activity that’s 60 times faster than traditional fMRI.